Leena Gandhi, Delvys Rodríguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Domine, Philip Clingan, Maximilian J Hochmair, Steven F Powell, Susanna Y-S Cheng, Helge G Bischoff, Nir Peled, Francesco Grossi, Ross R Jennens, Martin Reck, Rina Hui, Edward B Garon, Michael Boyer, Belén Rubio-Viqueira, Silvia Novello, Takayasu Kurata, Jhanelle E Gray, John Vida, Ziwen Wei, Jing Yang, Harry Raftopoulos, M Catherine Pietanza, Marina C Garassino. N Engl J Med 2018
Times Cited: 2818
Times Cited: 2818
Hossein Borghaei, Luis Paz-Ares, Leora Horn, David R Spigel, Martin Steins, Neal E Ready, Laura Q Chow, Everett E Vokes, Enriqueta Felip, Esther Holgado, Fabrice Barlesi, Martin Kohlhäufl, Oscar Arrieta, Marco Angelo Burgio, Jérôme Fayette, Hervé Lena, Elena Poddubskaya, David E Gerber, Scott N Gettinger, Charles M Rudin, Naiyer Rizvi, Lucio Crinò, George R Blumenschein, Scott J Antonia, Cécile Dorange, Christopher T Harbison, Friedrich Graf Finckenstein, Julie R Brahmer. N Engl J Med 2015
Times Cited: 5872
Times Cited: 5872
List of shared articles
Times cited
First-in-Humans Evaluation of a PD-L1-Binding Peptide PET Radiotracer in Non-Small Cell Lung Cancer Patients.
Xin Zhou, Jinquan Jiang, Xue Yang, Teli Liu, Jin Ding, Sridhar Nimmagadda, Martin G Pomper, Hua Zhu, Jun Zhao, Zhi Yang,[...]. J Nucl Med 2022
Xin Zhou, Jinquan Jiang, Xue Yang, Teli Liu, Jin Ding, Sridhar Nimmagadda, Martin G Pomper, Hua Zhu, Jun Zhao, Zhi Yang,[...]. J Nucl Med 2022
Tumor Immunology and Immunotherapy of Non-Small-Cell Lung Cancer.
Tina Cascone, Jared Fradette, Monika Pradhan, Don L Gibbons. Cold Spring Harb Perspect Med 2022
Tina Cascone, Jared Fradette, Monika Pradhan, Don L Gibbons. Cold Spring Harb Perspect Med 2022
Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition.
Marcus Unterrainer, Julian Taugner, Lukas Käsmann, Amanda Tufman, Niels Reinmuth, Minglun Li, Lena M Mittlmeier, Peter Bartenstein, Wolfgang G Kunz, Jens Ricke,[...]. Eur J Nucl Med Mol Imaging 2022
Marcus Unterrainer, Julian Taugner, Lukas Käsmann, Amanda Tufman, Niels Reinmuth, Minglun Li, Lena M Mittlmeier, Peter Bartenstein, Wolfgang G Kunz, Jens Ricke,[...]. Eur J Nucl Med Mol Imaging 2022
Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer.
Peiliang Wang, Tianwen Yin, Kaikai Zhao, Jinming Yu, Feifei Teng. J Cancer Res Clin Oncol 2022
Peiliang Wang, Tianwen Yin, Kaikai Zhao, Jinming Yu, Feifei Teng. J Cancer Res Clin Oncol 2022
Discontinuation of immune checkpoint inhibitor (ICI) above 18 months of treatment in real-life patients with advanced non-small cell lung cancer (NSCLC): INTEPI, a multicentric retrospective study.
Geoffroy Bilger, Nicolas Girard, Hélène Doubre, Matteo Giaj Levra, Etienne Giroux-Leprieur, Frederique Giraud, Chantal Decroisette, Matthieu Carton, Marie Ange Massiani. Cancer Immunol Immunother 2022
Geoffroy Bilger, Nicolas Girard, Hélène Doubre, Matteo Giaj Levra, Etienne Giroux-Leprieur, Frederique Giraud, Chantal Decroisette, Matthieu Carton, Marie Ange Massiani. Cancer Immunol Immunother 2022
Rational administration sequencing of immunochemotherapy elicits powerful anti-tumor effect.
Chunqi Zhu, Yingying Shi, Qingpo Li, Lihua Luo, Xiang Li, Zhenyu Luo, Yichao Lu, Junlei Zhang, Mengshi Jiang, Bing Qin,[...]. J Control Release 2022
Chunqi Zhu, Yingying Shi, Qingpo Li, Lihua Luo, Xiang Li, Zhenyu Luo, Yichao Lu, Junlei Zhang, Mengshi Jiang, Bing Qin,[...]. J Control Release 2022
IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer.
O Molinier, B Besse, F Barlesi, C Audigier-Valette, S Friard, I Monnet, G Jeannin, J Mazières, J Cadranel, J Hureaux,[...]. ESMO Open 2022
O Molinier, B Besse, F Barlesi, C Audigier-Valette, S Friard, I Monnet, G Jeannin, J Mazières, J Cadranel, J Hureaux,[...]. ESMO Open 2022
Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study.
Mette T Mouritzen, Karen F Junker, Andreas Carus, Morten Ladekarl, Peter Meldgaard, Anders W M Nielsen, Anna Livbjerg, Jacob W Larsen, Halla Skuladottir, Charlotte Kristiansen,[...]. Acta Oncol 2022
Mette T Mouritzen, Karen F Junker, Andreas Carus, Morten Ladekarl, Peter Meldgaard, Anders W M Nielsen, Anna Livbjerg, Jacob W Larsen, Halla Skuladottir, Charlotte Kristiansen,[...]. Acta Oncol 2022
The impact of gender on The efficacy of immune checkpoint inhibitors in cancer patients: The MOUSEION-01 study.
Matteo Santoni, Alessandro Rizzo, Veronica Mollica, Marc R Matrana, Matteo Rosellini, Luca Faloppi, Andrea Marchetti, Nicola Battelli, Francesco Massari. Crit Rev Oncol Hematol 2022
Matteo Santoni, Alessandro Rizzo, Veronica Mollica, Marc R Matrana, Matteo Rosellini, Luca Faloppi, Andrea Marchetti, Nicola Battelli, Francesco Massari. Crit Rev Oncol Hematol 2022
Effect of prior antibiotic or chemotherapy treatment on immunotherapy response in non-small cell lung cancer.
Andrew F Nyein, Shahla Bari, Stephanie Hogue, Yayi Zhao, Bradley Maller, Sybil Sha, Maria F Gomez, Dana E Rollison, Lary A Robinson. BMC Cancer 2022
Andrew F Nyein, Shahla Bari, Stephanie Hogue, Yayi Zhao, Bradley Maller, Sybil Sha, Maria F Gomez, Dana E Rollison, Lary A Robinson. BMC Cancer 2022
Prognostic and Immunological Role of FAT Family Genes in Non-Small Cell Lung Cancer.
Zhenxing Feng, Yan Yin, Bin Liu, Yafang Zheng, Dongsheng Shi, Hong Zhang, Jianwen Qin. Cancer Control 2022
Zhenxing Feng, Yan Yin, Bin Liu, Yafang Zheng, Dongsheng Shi, Hong Zhang, Jianwen Qin. Cancer Control 2022
Neutrophil Extracellular Traps in Cancer Therapy Resistance.
Muhammad H Shahzad, Lixuan Feng, Xin Su, Ariane Brassard, Iqraa Dhoparee-Doomah, Lorenzo E Ferri, Jonathan D Spicer, Jonathan J Cools-Lartigue. Cancers (Basel) 2022
Muhammad H Shahzad, Lixuan Feng, Xin Su, Ariane Brassard, Iqraa Dhoparee-Doomah, Lorenzo E Ferri, Jonathan D Spicer, Jonathan J Cools-Lartigue. Cancers (Basel) 2022
PD-1/L1 inhibitors may increase the risk of pericardial disease in non-small-cell lung cancer patients: a meta-analysis and systematic review.
Honglin Li, Deting Han, Lei Zhang, Xiaoteng Feng, Huijie Li, Feiran Yang, Lucheng Song, Xiurong Li. Immunotherapy 2022
Honglin Li, Deting Han, Lei Zhang, Xiaoteng Feng, Huijie Li, Feiran Yang, Lucheng Song, Xiurong Li. Immunotherapy 2022
A retrospective cohort study of sintilimab and pembrolizumab as first-line treatments for advanced non-small cell lung cancer.
Kai Wu, Yifan Fu, Daxiong Zeng, Tao Chen, Changguo Wang, Junhong Jiang. J Thorac Dis 2022
Kai Wu, Yifan Fu, Daxiong Zeng, Tao Chen, Changguo Wang, Junhong Jiang. J Thorac Dis 2022
Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab.
Giulia Pasello, Martina Lorenzi, Lorenzo Calvetti, Cristina Oliani, Alberto Pavan, Adolfo Favaretto, Giovanni Palazzolo, Petros Giovanis, Fable Zustovich, Andrea Bonetti,[...]. Oncologist 2022
Giulia Pasello, Martina Lorenzi, Lorenzo Calvetti, Cristina Oliani, Alberto Pavan, Adolfo Favaretto, Giovanni Palazzolo, Petros Giovanis, Fable Zustovich, Andrea Bonetti,[...]. Oncologist 2022
Inhibitors of PD-1 in Non-Small Cell Lung Cancer: A Meta-Analysis of Clinical and Molecular Features.
Gengwei Huo, Wenjie Liu, Peng Chen. Front Immunol 2022
Gengwei Huo, Wenjie Liu, Peng Chen. Front Immunol 2022
Efficacy and safety of sintilimab plus docetaxel in patients with previously treated advanced non-small cell lung cancer: a prospective, single-arm, phase II study in China.
Xiao Han, Jun Guo, Xiaoyong Tang, Hui Zhu, Dongyuan Zhu, Xiqin Zhang, Xiangjiao Meng, Ying Hua, Zhongtang Wang, Yan Zhang,[...]. J Cancer Res Clin Oncol 2022
Xiao Han, Jun Guo, Xiaoyong Tang, Hui Zhu, Dongyuan Zhu, Xiqin Zhang, Xiangjiao Meng, Ying Hua, Zhongtang Wang, Yan Zhang,[...]. J Cancer Res Clin Oncol 2022
Association of Personal Characteristics and Effectiveness of Immunotherapy in Late-Stage Non-Small Cell Lung Cancer: A Systematic Review.
Krishna Patel, Naomi Alpert, Stephanie Tuminello, Emanuela Taioli. JNCI Cancer Spectr 2022
Krishna Patel, Naomi Alpert, Stephanie Tuminello, Emanuela Taioli. JNCI Cancer Spectr 2022
Relationship between Patients' Baseline Characteristics and Survival Benefits in Immunotherapy-Treated Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Xuanbo Hu, Yafeng Liu, Yuxiao He, Zibo Wang, Hongyan Zhang, Wei Yang, Jibin Lu. J Oncol 2022
Xuanbo Hu, Yafeng Liu, Yuxiao He, Zibo Wang, Hongyan Zhang, Wei Yang, Jibin Lu. J Oncol 2022
Safety of immune checkpoint inhibitors in non-small-cell lung cancer patients with idiopathic interstitial pneumonia: a matched case-control study.
Takenori Ichimura, Miwa Hinata, Daisuke Ichikura, Shinya Suzuki. Cancer Chemother Pharmacol 2022
Takenori Ichimura, Miwa Hinata, Daisuke Ichikura, Shinya Suzuki. Cancer Chemother Pharmacol 2022
PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer.
Miho Takahashi, Satoshi Watanabe, Ryo Suzuki, Masashi Arita, Ko Sato, Miyuki Sato, Yuki Sekiya, Yuko Abe, Toshiya Fujisaki, Aya Ohtsubo,[...]. Cancer Immunol Immunother 2022
Miho Takahashi, Satoshi Watanabe, Ryo Suzuki, Masashi Arita, Ko Sato, Miyuki Sato, Yuki Sekiya, Yuko Abe, Toshiya Fujisaki, Aya Ohtsubo,[...]. Cancer Immunol Immunother 2022
Efficacy of PD-1/L1 inhibitors in brain metastases of non-small-cell lung cancer: pooled analysis from seven randomized controlled trials.
Wenjing Li, Jingwei Jiang, Lizhen Huang, Feng Long. Future Oncol 2022
Wenjing Li, Jingwei Jiang, Lizhen Huang, Feng Long. Future Oncol 2022
The immune modifying effects of chemotherapy and advances in chemo-immunotherapy.
Daniel R Principe, Suneel D Kamath, Murray Korc, Hidayatullah G Munshi. Pharmacol Ther 2022
Daniel R Principe, Suneel D Kamath, Murray Korc, Hidayatullah G Munshi. Pharmacol Ther 2022
Inflammatory Thoracic Aortic Aneurysm in a Patient with Advanced Lung Adenocarcinoma Treated with Pembrolizumab.
Ryusuke Ninomiya, Yuhei Kinehara, Satoshi Tobita, Hachiro Konaka, Ryu Jokoji, Takashi Shintani, Isao Tachibana. Intern Med 2022
Ryusuke Ninomiya, Yuhei Kinehara, Satoshi Tobita, Hachiro Konaka, Ryu Jokoji, Takashi Shintani, Isao Tachibana. Intern Med 2022
Chemoimmunotherapy for EGFR-Mutant NSCLC: Still No Clear Answer.
Bharathi Muthusamy, Nathan Pennell. J Thorac Oncol 2022
Bharathi Muthusamy, Nathan Pennell. J Thorac Oncol 2022
Generalizability of immune checkpoint inhibitor trials to real-world patients with advanced non-small cell lung cancer.
Monica Tang, Chee K Lee, Craig R Lewis, Michael Boyer, Bernadette Brown, Andrea Schaffer, Sallie-Anne Pearson, Robert J Simes. Lung Cancer 2022
Monica Tang, Chee K Lee, Craig R Lewis, Michael Boyer, Bernadette Brown, Andrea Schaffer, Sallie-Anne Pearson, Robert J Simes. Lung Cancer 2022